Human Papillomavirus-driven repression of NRF2 signaling confers chemosensitivity and predicts prognosis in head and neck squamous cell carcinoma
Pushkal Sinduvadi Ramesh(JSS Academy of Higher Education and Research), Rajesh K. Thimmulappa(Johns Hopkins University)
Cited by 0
Related Papers
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
|Journal of Clinical Investigation|2006|1k
NRF2 signaling is repressed in HPV-driven head and neck cancer and correlates with better prognosis: HPV-E6/E7 confers chemosensitivity by inhibiting NRF2
|Research Square|2022|1
Role of Oxacillin Susceptibility Testing Strategy in Changing Scenario of mecA Positive Staphylococcus aureus Isolates (OS-MRSA) Detection
|Journal of Pure and Applied Microbiology|2023|1